Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CONX > SEC Filings for CONX > Form 8-K on 19-Dec-2013All Recent SEC Filings

Show all filings for CORGENIX MEDICAL CORP/CO | Request a Trial to NEW EDGAR Online Pro

Form 8-K for CORGENIX MEDICAL CORP/CO


19-Dec-2013

Change in Directors or Principal Officers, Submission of Matters to a Vo


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

At the annual meeting of the shareholders of Corgenix Medical Corporation (the "Company") held on December 17, 2013 (the "Annual Meeting of Shareholders"), the Company's shareholders approved the Corgenix Medical Corporation Fourth Amended and Restated Employee Stock Purchase Plan (the "Plan"). The Plan had been previously approved, subject to shareholder approval, by the Board of Directors of the Company.

A description of the material terms of the Plan is set forth under the heading "Proposal 5 - Approval of the Fourth Amended and Restated Employee Stock Purchase Plan" in the Company's proxy statement filed with the Securities and Exchange Commission on November 5, 2013, which description is hereby incorporated by reference into this Item 5.02(e). In addition, a copy of the Plan was filed with the Company's Schedule 14A on November 5, 2013, as Appendix A, and is incorporated herein by reference, and this summary is qualified in its entirety by reference to the terms and provisions of the Plan.



Item 5.07. Submission of Matters to a Vote of Security Holders.

On December 17, 2013, the Company held its Annual Meeting of Shareholders, where the shareholders voted on the matters set forth below:

1. Proposal to elect seven directors to serve until the next annual meeting of shareholders and until their successors have been duly elected and qualified. Proxies were solicited by management in favor of the director nominees, with no solicitation in opposition to management's nominees. All seven director nominees were elected to serve for a period of one year until the Company's next Annual Meeting of Shareholders. The number of votes cast for, or withheld, as well as the number of broker non-votes, for each nominee was as follows:

                                                           Broker
Nominee                Votes Cast For   Votes Withheld   Non-Votes
Dennis Fusco               27,730,629          634,115   15,963,373
Douglass T. Simpson        27,714,831          649,913   15,963,373
Robert Tutag               27,710,958          653,786   15,963,373
Dr. Brandon J. Price       27,730,429          634,315   15,963,373
David Ludvigson            27,730,629          634,115   15,963,373
Dennis Walczewski          27,730,629          634,115   15,963,373
Stephen P. Gouze           27,730,609          634,135   15,963,373

2. Proposal to ratify the appointment of Hein & Associates LLP as the Company's independent public accountants for the fiscal year ending June 30, 2014. The appointment was ratified, and number of votes cast for, against, or abstained were as follows:

For Against Abstain
44,268,898 53,332 5,887

There were no broker non-votes for this proposal.

3. Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers (Say-on-Pay). The proposal was approved, on a non-binding basis, and the number of advisory votes cast for, against, or abstained were as follows:

For Against Abstain
27,623,866 713,578 27,300

There were 15,963,373 broker non-votes for this proposal.


4. Proposal to vote, on a non-binding advisory basis, on the frequency (i.e., every one, two, or three years) of holding a shareholder vote on executive compensation (Say-On-Frequency). The Board of Directors of the Company recommended a vote for every 3 years, but instead the most shareholder votes were cast for every 1 year. The voting results for the advisory vote on the frequency of shareholder advisory votes on executive compensation were as follows:

Every 1 Year Every 2 Years Every 3 Years Abstain 20,259,211 531,541 7,549,597 24,395

There were 15,963,373 broker non-votes for this proposal.

Consistent with the shareholder votes at the Annual Meeting of Shareholders, the Board of Directors has determined that the Company will hold a non-binding, advisory vote on the compensation of the Company's named executive officers once every year until the next say-on-frequency vote.

5. Proposal to approve the Corgenix Medical Corporation Fourth Amended and Restated Employee Stock Purchase Plan. The proposal was approved, and the number of votes cast for, against, or abstained were as follows:

For Against Abstain
27,408,989 946,955 8,800

There were 15,963,373 broker non-votes for this proposal.



Item 7.01. Regulation FD Disclosure.

At the Annual Meeting of Shareholders on December 17, 2013 the Company's President and Chief Executive Officer and Chief Financial Officer presented materials to shareholders which are filed as Exhibit 99.1 hereto and incorporated by reference.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

10.1   Fourth Amended and Restated Employee Stock Purchase Plan, filed with the
       Company's Schedule 14A on November 5, 2013, as Appendix A and incorporated
       herein by reference.

99.1   Shareholder presentation material of the President and Chief Executive
       Officer and the Chief Financial Officer of the Company used at the Annual
       Meeting of Shareholders on December 17, 2013.


  Add CONX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CONX - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.